Sfoglia per Autore
The Defective Proliferation of Vgamma9Vdelta2 T Cells to Zoledronic Acid In Chronic Lymphocytic Leukemia (CLL) Is a Powerful Time to First Treatment (TFT) Predictor Associated with the IGHV Mutational Status.
2010-01-01 Marta Coscia; Candida Vitale; Silvia Peola; Chiara Riganti; Daniela Angelini; Myriam Foglietta; Francesca Pantaleoni; Giorgia Matta; Sabina Chiaretti; Anna Guarini; Daniela Drandi; Marco Ladetto; Amalia Bosia; Luca Battistini; Robin Foà; Mario Boccadoro; Jean-Jacques Fournié; Massimo Massaia
IGHV Unmutated Chronic Lymphocytic Leukemia (CLL) B Cells Are More Susceptible to Spontaneous Apoptosis Than Mutated CLL B Cells and Are Subject to the Anti-Apoptotic Effect of Environmental Signals
2010-01-01 Marta Coscia; Francesca Pantaleoni; Chiara Riganti; Candida Vitale; Micol Rigoni; Silvia Peola; Daniela Drandi; Barbara Castella; Marina Ruggeri; Paola Omedè; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia
EXPRESSION OF MET MRNA AS PROGNOSTIC MARKER IN MULTIPLE MYELOMA PATIENTS TREATED WITH NOVEL DRUGS
2010-01-01 Rocci A; Gambella M; Trusolino L; Gay F; Omedè P; Magarotto V; Bertotti A; Montefusco V; Crippa C; Patriarca F; Gilestro M; Liberati AM; Gaidano G; Di Raimondo F; Falcone A; Rossi G; Drandi D; Corradini P; Ladetto M; Comoglio PM; Boccadoro M; Palumbo A
Telomere lenght measurement in the clinically oriented research setting: a comparison between Southern blot (SB), real time quantitative PCR (RQ-PCR) and FLOW-FISH (FF)
2011-01-01 Genuardi E; Ruggeri M; Drandi D; Caltagirone S; Mastrocola R; Bernocco E; Lobetti Bodoni C; Boi M; Monitillo L; Mantoan B; Mantella E; Isaia G; Bergui L; Coscia M; Boccadoro M; Massaia M; Omedè P; Ladetto M
IGHV UNMUTATED CLL B CELLS ARE MORE PRONE TO SPONTANEOUS APOPTOSIS AND DEPEND FROM THE ANTI-APOPTOTIC EFFECT OF ENVIRONMENTAL SIGNALS
2011-01-01 Marta Coscia; Francesca Pantaleoni; Chiara Riganti; Candida Vitale; Micol Rigoni; Silvia Peola; Daniela Drandi; Marco Ladetto; Marina Ruggeri; Valentina Griggio; Barbara Castella; Patrizia Sciancalepore; Paola Omedè; Amalia Bosia; Mario Boccadoro; Massimo Massaia
Identification by serological proteome analysis (SERPA) of tumor-associated antigens eliciting antibody-responses in chronic lymphocytic leukemia
2011-01-01 Griggio V; Capello M; Linty F; Vitale C; Peola S; Cappello P; Castella B; Rigoni M; Sciancalepore P; Drandi D; Ruggeri M; Omedè P; Ladetto M; Novelli F; Boccadoro M; Massaia M; Coscia M
IMPACT OF THE MEVALONATE PATHWAY AND HIF/PGP AXIS IN MODULATING MULTIDRUG-RESISTANCE IN UNMUTATED CLL CELLS
2011-01-01 Marta Coscia; Micol Rigoni; Chiara Riganti; Ivana Campia; Candida Vitale; Silvia Peola; Barbara Castella; Valentina Griggio; Francesca Pantaleoni; Patrizia Sciancalepore; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia
Targeting the mevalonate pathway and downstream signaling pathways as a strategy to circumvent multidrug-resistance in CLL cells
2011-01-01 Rigoni M; Coscia M; Riganti C; Campia I; Vitale C; Peola S; Castella B; Griggio V; Pantaleoni F; Sciancalepore P; Drandi D; Ladetto M; Bosia A; Boccadoro M; Massaia M
Progressive telomere shortening occurs during the natural history of chronic lymphocytic leukemia (CLL) and associates to outcome
2011-01-01 Bernocco E; Rossi D; Genuardi E; Lobetti-Bodoni C; Drandi D; Coscia M; Ruggeri M; Fangazio M; Ghione P; Antico O; Zanni M; Gattei V; Bergui L; Omedè P; Massaia M; Boccadoro M; Gaidano G; Ladetto M
Identification by serological proteome analysis (SERPA) of novel tumor associated antigens in chronic lymphocytic leukemia (CLL)
2011-01-01 M Coscia; V Griggio; M Capello; C Vitale; F Linty; S Peola; P Cappello; B Castella; M Rigoni; P Sciancalepore; D Drandi; M Ruggeri; P Omedè; M Ladetto; F Novelli; M Boccadoro; M Massaia
SEROLOGICAL PROTEOME ANALYSIS (SERPA) FOR THE IDENTIFICATION OF TUMOR-ASSOCIATED ANTIGENS ELICITING ANTIBODY-RESPONSES IN CHRONIC LYMPHOCYTIC LEUKEMIA
2011-01-01 M. Coscia; V. Griggio; M. Capello; F. Linty; C. Vitale; S. Peola; P. Cappello; B. Castella; M. Rigoni; P. Sciancalepore; D. Drandi; M. Ruggeri; P. Omedè; M. Ladetto; F. Novelli; M. Boccadoro; M. Massaia
Progressive Telomere Shortening Is Part of the Natural History of Chronic Lymphocytic Leukemia (CLL) and Impacts Clinical Outcom
2011-01-01 Elisa Bernocco; Davide Rossi; Elisa Genuardi; Chiara Lobetti-Bodoni; Roberto Passera; Daniela Drandi; Marta Coscia; Marina Ruggeri; Marco Fangazio; Paola Ghione; Daniela Barbero; Barbara Mantoan; Sara Barbiero; Manuela Zanni; Valter Gattei; Luciana Bergui; Paola Omedè; Massimo Massaia; Mario Boccadoro; Gianluca Gaidano; Marco Ladetto
LONG-TERM RESULTS of the GIMEMA VTD Consolidation TRIAL In Autografted MULTIPLE Myeloma PATIENTS (VEL-03-096): IMPACT of Minimal RESIDUAL DISEASE Detection by REAL Time Quantitative PCR On LATE Recurrences and Overall SURVIVAL
2011-01-01 Ladetto M.; Ferrero S.; Drandi D.; Cavallo F.; Monitillo L.; et al.
The Mevalonate Pathway As a Metabolic Target to Circumvent Multidrug-Resistance in Chronic Lymphocytic Leukemia Cells
2011-01-01 Marta Coscia; Micol Rigoni; Chiara Riganti; Ivana Campia; Candida Vitale; Valentina Griggio; Silvia Peola; Barbara Castella; Patrizia Sciancalepore; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia
PROGRESSIVE TELOMERE SHORTENING DURING THE NATURAL HISTORY OF CHRONIC LYMPHOCYTIC LEUKEMIA
2011-01-01 Genuardi, E; Rossi, D; Bernocco, E; Bodoni, Cl; Drandi, D; Coscia, M; Ruggeri, M; Fangazio, M; Ghione, P; Gattei, V; Boccadoro, M; Omede, P; Massaia, M; Gaidano, G; Ladetto, M
IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells
2011-01-01 Coscia M; Pantaleoni F; Riganti C; Vitale C; Rigoni M; Peola S; Castella B; Foglietta M; Griggio V; Drandi D; Ladetto M; Bosia A; Boccadoro M; Massaia M.
Accelerated activity of the mevalonate pathway supports the immune escape and multidrug-resistance phenotype of IGHV unmutated chronic lymphocytic leukemia cells
2011-01-01 M Coscia; M Rigoni; C Riganti; I Campia; C Vitale; V Griggio; S Peola; B Castella; F Pantaleoni; P Sciancalepore; D Drandi; P Omedè; M Ladetto; A Bosia; M Boccadoro; M Massaia
Expression of telomeric proteins in chronic lymphocytic leukemia (CLL)
2011-01-01 Barbero D; Drandi D; Lobetti Bodoni C; Bernocco E; Coscia M; Ruggeri M; Boi M; Genuardi E; Monitillo L; Mantoan B; Maffeo C; Barbiero S; Ferrero S; Rossi D; Passera R; Gaidano G; Massaia M; Omedè P; Boccadoro M; Ladetto M
SEROLOGICAL PROTEOME ANALYSIS (SERPA) FOR THEIDENTIFICATION OF NOVEL TUMOR-ASSOCIATED ANTIGENS INCHRONIC LYMPHOCYTIC LEUKEMIA
2011-01-01 M. Coscia; V. Griggio; M. Capello; F. Linty; C. Vitale; S. Peola; B. Castella; M. Rigoni; D. Drandi; M. Ruggeri; P. Omede`; M. Ladetto; F. Novelli; M. Boccadoro; M. Massaia
Minimal residual disease detection in lymphoma and multiple myeloma: impact on therapeutic paradigms
2011-01-01 Simone Ferrero;Daniela Drandi;Barbara Mantoan;Paola Ghione;Paola Omedè;Marco Ladetto
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| The Defective Proliferation of Vgamma9Vdelta2 T Cells to Zoledronic Acid In Chronic Lymphocytic Leukemia (CLL) Is a Powerful Time to First Treatment (TFT) Predictor Associated with the IGHV Mutational Status. | 2010 | Marta Coscia; Candida Vitale; Silvia Peola; Chiara Riganti; Daniela Angelini; Myriam Foglietta; Francesca Pantaleoni; Giorgia Matta; Sabina Chiaretti; Anna Guarini; Daniela Drandi; Marco Ladetto; Amalia Bosia; Luca Battistini; Robin Foà; Mario Boccadoro; Jean-Jacques Fournié; Massimo Massaia | |
| IGHV Unmutated Chronic Lymphocytic Leukemia (CLL) B Cells Are More Susceptible to Spontaneous Apoptosis Than Mutated CLL B Cells and Are Subject to the Anti-Apoptotic Effect of Environmental Signals | 2010 | Marta Coscia; Francesca Pantaleoni; Chiara Riganti; Candida Vitale; Micol Rigoni; Silvia Peola; Daniela Drandi; Barbara Castella; Marina Ruggeri; Paola Omedè; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia | |
| EXPRESSION OF MET MRNA AS PROGNOSTIC MARKER IN MULTIPLE MYELOMA PATIENTS TREATED WITH NOVEL DRUGS | 2010 | Rocci A; Gambella M; Trusolino L; Gay F; Omedè P; Magarotto V; Bertotti A; Montefusco V; Crippa C; Patriarca F; Gilestro M; Liberati AM; Gaidano G; Di Raimondo F; Falcone A; Rossi G; Drandi D; Corradini P; Ladetto M; Comoglio PM; Boccadoro M; Palumbo A | |
| Telomere lenght measurement in the clinically oriented research setting: a comparison between Southern blot (SB), real time quantitative PCR (RQ-PCR) and FLOW-FISH (FF) | 2011 | Genuardi E; Ruggeri M; Drandi D; Caltagirone S; Mastrocola R; Bernocco E; Lobetti Bodoni C; Boi M; Monitillo L; Mantoan B; Mantella E; Isaia G; Bergui L; Coscia M; Boccadoro M; Massaia M; Omedè P; Ladetto M | |
| IGHV UNMUTATED CLL B CELLS ARE MORE PRONE TO SPONTANEOUS APOPTOSIS AND DEPEND FROM THE ANTI-APOPTOTIC EFFECT OF ENVIRONMENTAL SIGNALS | 2011 | Marta Coscia; Francesca Pantaleoni; Chiara Riganti; Candida Vitale; Micol Rigoni; Silvia Peola; Daniela Drandi; Marco Ladetto; Marina Ruggeri; Valentina Griggio; Barbara Castella; Patrizia Sciancalepore; Paola Omedè; Amalia Bosia; Mario Boccadoro; Massimo Massaia | |
| Identification by serological proteome analysis (SERPA) of tumor-associated antigens eliciting antibody-responses in chronic lymphocytic leukemia | 2011 | Griggio V; Capello M; Linty F; Vitale C; Peola S; Cappello P; Castella B; Rigoni M; Sciancalepore P; Drandi D; Ruggeri M; Omedè P; Ladetto M; Novelli F; Boccadoro M; Massaia M; Coscia M | |
| IMPACT OF THE MEVALONATE PATHWAY AND HIF/PGP AXIS IN MODULATING MULTIDRUG-RESISTANCE IN UNMUTATED CLL CELLS | 2011 | Marta Coscia; Micol Rigoni; Chiara Riganti; Ivana Campia; Candida Vitale; Silvia Peola; Barbara Castella; Valentina Griggio; Francesca Pantaleoni; Patrizia Sciancalepore; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia | |
| Targeting the mevalonate pathway and downstream signaling pathways as a strategy to circumvent multidrug-resistance in CLL cells | 2011 | Rigoni M; Coscia M; Riganti C; Campia I; Vitale C; Peola S; Castella B; Griggio V; Pantaleoni F; Sciancalepore P; Drandi D; Ladetto M; Bosia A; Boccadoro M; Massaia M | |
| Progressive telomere shortening occurs during the natural history of chronic lymphocytic leukemia (CLL) and associates to outcome | 2011 | Bernocco E; Rossi D; Genuardi E; Lobetti-Bodoni C; Drandi D; Coscia M; Ruggeri M; Fangazio M; Ghione P; Antico O; Zanni M; Gattei V; Bergui L; Omedè P; Massaia M; Boccadoro M; Gaidano G; Ladetto M | |
| Identification by serological proteome analysis (SERPA) of novel tumor associated antigens in chronic lymphocytic leukemia (CLL) | 2011 | M Coscia; V Griggio; M Capello; C Vitale; F Linty; S Peola; P Cappello; B Castella; M Rigoni; P Sciancalepore; D Drandi; M Ruggeri; P Omedè; M Ladetto; F Novelli; M Boccadoro; M Massaia | |
| SEROLOGICAL PROTEOME ANALYSIS (SERPA) FOR THE IDENTIFICATION OF TUMOR-ASSOCIATED ANTIGENS ELICITING ANTIBODY-RESPONSES IN CHRONIC LYMPHOCYTIC LEUKEMIA | 2011 | M. Coscia; V. Griggio; M. Capello; F. Linty; C. Vitale; S. Peola; P. Cappello; B. Castella; M. Rigoni; P. Sciancalepore; D. Drandi; M. Ruggeri; P. Omedè; M. Ladetto; F. Novelli; M. Boccadoro; M. Massaia | |
| Progressive Telomere Shortening Is Part of the Natural History of Chronic Lymphocytic Leukemia (CLL) and Impacts Clinical Outcom | 2011 | Elisa Bernocco; Davide Rossi; Elisa Genuardi; Chiara Lobetti-Bodoni; Roberto Passera; Daniela Drandi; Marta Coscia; Marina Ruggeri; Marco Fangazio; Paola Ghione; Daniela Barbero; Barbara Mantoan; Sara Barbiero; Manuela Zanni; Valter Gattei; Luciana Bergui; Paola Omedè; Massimo Massaia; Mario Boccadoro; Gianluca Gaidano; Marco Ladetto | |
| LONG-TERM RESULTS of the GIMEMA VTD Consolidation TRIAL In Autografted MULTIPLE Myeloma PATIENTS (VEL-03-096): IMPACT of Minimal RESIDUAL DISEASE Detection by REAL Time Quantitative PCR On LATE Recurrences and Overall SURVIVAL | 2011 | Ladetto M.; Ferrero S.; Drandi D.; Cavallo F.; Monitillo L.; et al. | |
| The Mevalonate Pathway As a Metabolic Target to Circumvent Multidrug-Resistance in Chronic Lymphocytic Leukemia Cells | 2011 | Marta Coscia; Micol Rigoni; Chiara Riganti; Ivana Campia; Candida Vitale; Valentina Griggio; Silvia Peola; Barbara Castella; Patrizia Sciancalepore; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia | |
| PROGRESSIVE TELOMERE SHORTENING DURING THE NATURAL HISTORY OF CHRONIC LYMPHOCYTIC LEUKEMIA | 2011 | Genuardi, E; Rossi, D; Bernocco, E; Bodoni, Cl; Drandi, D; Coscia, M; Ruggeri, M; Fangazio, M; Ghione, P; Gattei, V; Boccadoro, M; Omede, P; Massaia, M; Gaidano, G; Ladetto, M | |
| IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells | 2011 | Coscia M; Pantaleoni F; Riganti C; Vitale C; Rigoni M; Peola S; Castella B; Foglietta M; Griggio V; Drandi D; Ladetto M; Bosia A; Boccadoro M; Massaia M. | |
| Accelerated activity of the mevalonate pathway supports the immune escape and multidrug-resistance phenotype of IGHV unmutated chronic lymphocytic leukemia cells | 2011 | M Coscia; M Rigoni; C Riganti; I Campia; C Vitale; V Griggio; S Peola; B Castella; F Pantaleoni; P Sciancalepore; D Drandi; P Omedè; M Ladetto; A Bosia; M Boccadoro; M Massaia | |
| Expression of telomeric proteins in chronic lymphocytic leukemia (CLL) | 2011 | Barbero D; Drandi D; Lobetti Bodoni C; Bernocco E; Coscia M; Ruggeri M; Boi M; Genuardi E; Monitillo L; Mantoan B; Maffeo C; Barbiero S; Ferrero S; Rossi D; Passera R; Gaidano G; Massaia M; Omedè P; Boccadoro M; Ladetto M | |
| SEROLOGICAL PROTEOME ANALYSIS (SERPA) FOR THEIDENTIFICATION OF NOVEL TUMOR-ASSOCIATED ANTIGENS INCHRONIC LYMPHOCYTIC LEUKEMIA | 2011 | M. Coscia; V. Griggio; M. Capello; F. Linty; C. Vitale; S. Peola; B. Castella; M. Rigoni; D. Drandi; M. Ruggeri; P. Omede`; M. Ladetto; F. Novelli; M. Boccadoro; M. Massaia | |
| Minimal residual disease detection in lymphoma and multiple myeloma: impact on therapeutic paradigms | 2011 | Simone Ferrero;Daniela Drandi;Barbara Mantoan;Paola Ghione;Paola Omedè;Marco Ladetto |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile